These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 38984824

  • 1. Double blaKPC-2 copies quadrupled minimum inhibitory concentration of ceftazidime-avibactam in hospital-derived Klebsiella pneumoniae.
    Hu D, Wang S, Xu M, Zhang J, Luo X, Zhou W, Ma Q, Ma X.
    Microbiol Spectr; 2024 Aug 06; 12(8):e0033124. PubMed ID: 38984824
    [Abstract] [Full Text] [Related]

  • 2. Molecular mechanisms responsible KPC-135-mediated resistance to ceftazidime-avibactam in ST11-K47 hypervirulent Klebsiella pneumoniae.
    Shi Q, Shen S, Tang C, Ding L, Guo Y, Yang Y, Wu S, Han R, Yin D, Hu F.
    Emerg Microbes Infect; 2024 Dec 06; 13(1):2361007. PubMed ID: 38801099
    [Abstract] [Full Text] [Related]

  • 3. Emergence of ceftazidime-avibactam resistance in blaKPC-33-harbouring ST11 Klebsiella pneumoniae in a paediatric patient.
    Zhou J, Yan G, Tang C, Liu J, Fu P, Ding L, Yang W, Guo Y, Wang C, Lu G, Hu F.
    Int J Antimicrob Agents; 2024 Jun 06; 63(6):107163. PubMed ID: 38570018
    [Abstract] [Full Text] [Related]

  • 4. Molecular Mechanisms Driving the In Vivo Development of KPC-71-Mediated Resistance to Ceftazidime-Avibactam during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections.
    Li X, Ke H, Wu W, Tu Y, Zhou H, Yu Y.
    mSphere; 2021 Dec 22; 6(6):e0085921. PubMed ID: 34935448
    [Abstract] [Full Text] [Related]

  • 5. Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne blaKPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections.
    Shields RK, Chen L, Cheng S, Chavda KD, Press EG, Snyder A, Pandey R, Doi Y, Kreiswirth BN, Nguyen MH, Clancy CJ.
    Antimicrob Agents Chemother; 2017 Mar 22; 61(3):. PubMed ID: 28031201
    [Abstract] [Full Text] [Related]

  • 6. Reversion of KPC-114 to KPC-2 in ceftazidime-avibactam- resistant/meropenem-susceptible Klebsiella pneumoniae ST11 is related to low mutation rates.
    Pariona JGM, Vásquez-Ponce F, Becerra J, Martins-Gonçalves T, Pariona EMM, Madueño FT, Esposito F, V de Lima A, Mello Sampaio JL, Galhardo RS, Lincopan N.
    Microbiol Spectr; 2024 Oct 03; 12(10):e0117324. PubMed ID: 39190636
    [Abstract] [Full Text] [Related]

  • 7. A large-scale surveillance revealed that KPC variants mediated ceftazidime-avibactam resistance in clinically isolated Klebsiella pneumoniae.
    Qiao S, Xin S, Zhu Y, Zhao F, Wu H, Zhang J, Yao B, Yu Y, Fu Y, Jiang Y, Xie X, Zhang J.
    Microbiol Spectr; 2024 Aug 06; 12(8):e0025824. PubMed ID: 38958437
    [Abstract] [Full Text] [Related]

  • 8. KPC-2 allelic variants in Klebsiella pneumoniae isolates resistant to ceftazidime-avibactam from Argentina: blaKPC-80, blaKPC-81, blaKPC-96 and blaKPC-97.
    Sanz MB, Pasteran F, de Mendieta JM, Brunetti F, Albornoz E, Rapoport M, Lucero C, Errecalde L, Nuñez MR, Monge R, Pennini M, Power P, Corso A, Gomez SA.
    Microbiol Spectr; 2024 Mar 05; 12(3):e0411123. PubMed ID: 38319084
    [Abstract] [Full Text] [Related]

  • 9. Genomic characterization of a KPC-23-producing Klebsiella pneumoniae ST258 clinical isolate resistant to ceftazidime-avibactam.
    Galani I, Antoniadou A, Karaiskos I, Kontopoulou K, Giamarellou H, Souli M.
    Clin Microbiol Infect; 2019 Jun 05; 25(6):763.e5-763.e8. PubMed ID: 30928562
    [Abstract] [Full Text] [Related]

  • 10. Complex evolutionary trajectories in vivo of two novel KPC variants conferring ceftazidime-avibactam resistance.
    Tang C, Shen S, Yang W, Shi Q, Ding L, Han R, Yin D, Guo Y, Zhu D, Hu F.
    Int J Antimicrob Agents; 2024 Sep 05; 64(3):107265. PubMed ID: 38964622
    [Abstract] [Full Text] [Related]

  • 11. Ceftazidime-Avibactam Resistance Associated with Increased blaKPC-3 Gene Copy Number Mediated by pKpQIL Plasmid Derivatives in Sequence Type 258 Klebsiella pneumoniae.
    Coppi M, Di Pilato V, Monaco F, Giani T, Conaldi PG, Rossolini GM.
    Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 31964792
    [Abstract] [Full Text] [Related]

  • 12. Successive Emergence of Ceftazidime-Avibactam Resistance through Distinct Genomic Adaptations in blaKPC-2-Harboring Klebsiella pneumoniae Sequence Type 307 Isolates.
    Giddins MJ, Macesic N, Annavajhala MK, Stump S, Khan S, McConville TH, Mehta M, Gomez-Simmonds A, Uhlemann AC.
    Antimicrob Agents Chemother; 2018 Mar 24; 62(3):. PubMed ID: 29263067
    [Abstract] [Full Text] [Related]

  • 13. In vivo evolution to hypermucoviscosity and ceftazidime/avibactam resistance in a liver abscess caused by Klebsiella pneumoniae sequence type 512.
    Capitani V, Arcari G, Ambrosi C, Scribano D, Ceparano M, Polani R, De Francesco A, Raponi G, Ceccarelli G, Villari P, Palamara AT, Marzuillo C, Carattoli A.
    mSphere; 2024 Sep 25; 9(9):e0042324. PubMed ID: 39171923
    [Abstract] [Full Text] [Related]

  • 14. Evolution of blaKPC Under the Pressure of Carbapenems and Ceftazidime/Avibactam in a Patient With Persistent Bacteremia Caused by Klebsiella pneumoniae.
    Won EJ, Park K, Jeong YS, Kim J, Choi Y, Kim SH, Kim MN, Sung H.
    J Korean Med Sci; 2024 Jul 01; 39(25):e208. PubMed ID: 38952349
    [Abstract] [Full Text] [Related]

  • 15. In vitro mimicry of in vivo KPC mutations by ceftazidime-avibactam: phenotypes, mechanisms, genetic structure and kinetics of enzymatic hydrolysis.
    Shen S, Tang C, Yang W, Ding L, Han R, Shi Q, Guo Y, Yin D, Hu F.
    Emerg Microbes Infect; 2024 Dec 01; 13(1):2356146. PubMed ID: 38743401
    [Abstract] [Full Text] [Related]

  • 16. Dynamic evolution of ceftazidime-avibactam resistance from a single patient through the IncX3_NDM-5 plasmid transfer and blaKPC mutation.
    Tang C, Shen S, Yang W, Shi Q, Ding L, Han R, Hu F.
    Int J Antimicrob Agents; 2024 Aug 01; 64(2):107228. PubMed ID: 38823494
    [Abstract] [Full Text] [Related]

  • 17. A novel KPC-166 in ceftazidime/avibactam resistant ST307 Klebsiella pneumoniae causing an outbreak in intensive care COVID Unit, Italy.
    Piazza A, Mattioni Marchetti V, Bielli A, Biffignandi GB, Piscopiello F, Giudici R, Tartaglione L, Merli M, Vismara C, Migliavacca R.
    J Microbiol Immunol Infect; 2024 Jun 01; 57(3):457-469. PubMed ID: 38584042
    [Abstract] [Full Text] [Related]

  • 18. Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China.
    Zhang P, Shi Q, Hu H, Hong B, Wu X, Du X, Akova M, Yu Y.
    Clin Microbiol Infect; 2020 Jan 01; 26(1):124.e1-124.e4. PubMed ID: 31494252
    [Abstract] [Full Text] [Related]

  • 19. Loss and gain of ceftazidime-avibactam susceptibility in a non-carbapenemase-producing K1-ST23 hypervirulent Klebsiella pneumoniae.
    Zhao J, Pu D, Li Z, Zhang Y, Liu X, Zhuo X, Lu B, Cao B.
    Virulence; 2024 Dec 01; 15(1):2348251. PubMed ID: 38697754
    [Abstract] [Full Text] [Related]

  • 20. Investigation of the Rapid Emergence of Colistin Resistance in a Newborn Infected with KPC-2-Producing Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae.
    Wang J, Chen H, Li M, Guo Y, Liu S, Tu S, Zhang X, Zhang Y, Zhao C, Wang X, Wang H.
    J Glob Antimicrob Resist; 2024 Sep 01; 38():265-270. PubMed ID: 38849114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.